Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Groups of male and female Wistar rats received the analogue substance Pigment Red 170 at concentrations of 0, 500, 2500 or 12500 mg/kg food for a period of 28 days and were necropsied at day 29.

Behaviour and state of health were observed daily in all groups. Body weights and food consumption were recorded twice weekly and water consumption once weekly.

Hematological examinations, clinical chemistry and urine analysis were carried out at the termination of the study.

During necropsy the animals were examined for macroscopically visible abnormalities, the main organs weighed and the organ to bodyweight ratios calculated.

Many organs and tissues were processed for histopathological examination and checked for microscopically visible changes.

Body weights, hematological and clinical chemistry data, urine data (volume, pH value and specific weight), absolute and relative organ weights were analysed with the aid of a statistical program to show differences compared with the controls.

According to food consumption, mean substance intakes were as follows:

Males - low dose group               47 mg/kg bodyweight per day

intermediate dose group          227 mg/kg bodyweight per day

high dose group                      1172 mg/kg bodyweight per day

Females - low dose group      46 mg/kg bodyweight per day

intermediate dose group        236 mg/kg bodyweight per day

high dose group                          1193 mg/kg bodyweight per day

Behaviour and general health condition remained unaffected by the administration of the test compound in all groups. Body weight development, food and water consumption were comparable in all groups.

No signs of neurological disturbances, opacity of the refracting media of the eyes, damage to the oral mucosa or impairment of dental growth were observed in the control or treatment groups.

Hematological and clinical chemistry examinations revealed no abnormalities. No treatment-related changes were observed by urine analysis.

Organ weights were not affected by the administration of the test compound.

No compound-related effect was observed at necropsy.

The histopathological examinations revealed test compound in the lumen of the alimentary tract, adherent to the surface of the mucous membrane and/or the

food. The mucous membranes itself were uninjured.

In conclusion, Pigment Red 170 caused no detectable adverse effects in male and female Wistar rats when administered via food at the concentration of 12500 mg/kg food for 28 days.

With regard to the present study the 'No Observed Effect Level' is 12500 mg test item / kg food. This is equivalent to a mean daily compound intake of

1172 mg/kg bodyweight in males and 1193 mg/kg bodyweight in females.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Link to relevant study records
Reference
Endpoint:
short-term repeated dose toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1992-06-03 - 1992-07-01
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
Version / remarks:
1981
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Limit test:
no
Species:
rat
Strain:
Wistar
Remarks:
HOE: Wisk (SPF71)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Hoechst AG Frankfurt, Germany
- Females (if applicable) nulliparous and non-pregnant: [yes]
- Age at study initiation: not specified
- Weight at study initiation: Male: 134-137 g; female: 114 -117 g
- Fasting period before study: no
- Housing: groups of 5 in wire mesh cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 5 days


ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 C
- Humidity (%):50 +/- 20%
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12/12
Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Remarks:
admixture in food
Analytical verification of doses or concentrations:
yes
Duration of treatment / exposure:
28 days
Frequency of treatment:
daily
Dose / conc.:
0 mg/kg diet
Remarks:
Control
Dose / conc.:
500 mg/kg diet
Dose / conc.:
2 500 mg/kg diet
Dose / conc.:
12 500 mg/kg diet
No. of animals per sex per dose:
5
Control animals:
yes, plain diet
Positive control:
no
Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
- Cage side observations included: general behaviour & health, neurological abservations, teeht, eyes.

DETAILED CLINICAL OBSERVATIONS: Not specified
- Time schedule:

BODY WEIGHT: Yes
- Time schedule for examinations: weekly

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes, twice weekly
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Not specified

FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No

WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: weekly

OPHTHALMOSCOPIC EXAMINATION: Not specified

HAEMATOLOGY: Yes
- Time schedule for collection of blood: end of study
- Anaesthetic used for blood collection: Not specified
- Animals fasted: No
- How many animals: all
- Parameters were examined: RBC. Hb, Hematocrit, MCV, MCH, MCHC, Leuco, Platelets, Diff. Leuco, Rei, Heinzbodies, coagulation time

CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: end of study
- Animals fasted: No
- How many animals: all
- Parameters examined: Na, K, PO4, Uric acid, Bilirubin, Creatinine, Glucose, Ca, Cl, ASAT, ALAT, AP, gamma GT, Cholesterol, triglycerides, Tot. protein, tot. Lipids, Albumen, urea nitrogen

URINALYSIS: Yes
- Time schedule for collection of urine: shortly before end of study
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Not specified
- Parameters examined: Appearance, colour, Volume, pH, Hb, Protein, Glucose, Ketone bodies, Bilirubin, Urobiinogen, density, sediment,

NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations:daily,
- Dose groups that were examined: all
- Battery of functions tested: sensory activity , other: general observations

IMMUNOLOGY: No

OTHER:
Sacrifice and pathology:
GROSS PATHOLOGY: Yes

HISTOPATHOLOGY: Yes
Organweights: Heart lung, liver, kidneys, spleen
Histopathology: Heart lung, liver, kidneys, spleen, stomach, jejunum,colon, urinary bladder, testes,epididymides, prostate, seminal vesicles, ovaries, uterus, adrenals, thymus, brain, nstrachea, bone marrow (femur), skeletal muscle, nervus ischiadicus, spinal cord (3 locations), lymphnodes (2 locations)
Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
The red colouration of feces and fur is considered a non-adverse effect of the coloured test item.
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
no effects observed
Ophthalmological findings:
no effects observed
Haematological findings:
effects observed, non-treatment-related
Description (incidence and severity):
Decreased number of reticulocytes in high dose males without signs of anemia and within normal range of the strain used.
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Behaviour (functional findings):
not examined
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
effects observed, non-treatment-related
Description (incidence and severity):
Several, non dose related statistical variations were seen in differnt groups
Gross pathological findings:
no effects observed
Description (incidence and severity):
red coloured content of digestive tract was considered not adverse.
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
no effects observed
Histopathological findings: neoplastic:
no effects observed
Other effects:
not examined
Details on results:
According to food consumption, mean substance intakes were as follows:

Males
low dose group 47 mg/kg bodyweight per day
intermediate dose group 227 mg/kg bodyweight per day
high dose group 1172 mg/kg bodyweight per day

Females
low dose group 46 mg/kg bodyweight per day
intermediate dose group 236 mg/kg bodyweight per day
high dose group 1193 mg/kg bodyweight per day

Behaviour and general health condition remained unaffected by the administration of the test compound in all groups. Body weight development, food and water consumption were comparable in all groups.
No signs of neurological disturbances, opacity of the refracting media of the eyes, damage to the oral mucosa or impairment of dental growth were observed in the control or treatment groups.
Hematological and clinical chemistry examinations revealed no abnormalities.
No treatment-related changes were observed by urine analysis.
Organ weights were not affected by the administration of the test compound.
No compound-related effect was observed at necropsy.
The histopathological examinations revealed test compound in the lumen of the alimentary tract, adherent to the surface of the mucous membrane and/or the food. The mucous membranes themselves were uninjured.
In conclusion, Pigment Red 170 caused no detectable adverse effects in male and female Wistar rats when administered via food at the concentration of 12500 mg/kg food for 28 days.
With regard to the present study the 'No Observed Effect Level' is 12500 mg Pigment Red 170 /kg food. This is equivalent to a mean daily compound intake of
1172 mg/kg bodyweight in males and 1193 mg/kg bodyweight in females.
Key result
Dose descriptor:
NOAEL
Effect level:
>= 1 000 mg/kg bw/day (actual dose received)
Based on:
test mat.
Sex:
male/female
Remarks on result:
not determinable due to adverse toxic effects at highest dose / concentration tested
Key result
Critical effects observed:
no
Conclusions:
The test item caused no adverse effects after oral exposure for 28 days at doses up to more than 1000 mg/kg bw per day.
Executive summary:

Groups of male and female Wistar rats received Pigment Red 170 at concentrations of 0, 500, 2500 or 12500 mg/kg food for a period of 28 days and were necropsied at day 29.

Behaviour and state of health were observed daily in all groups. Body weights and food consumption were recorded twice weekly and water consumption once weekly.

Hematological examinations, clinical chemistry and urine analysis were carried out at the termination of the study.

During necropsy the animals were examined for macroscopically visible abnormalities, the main organs weighed and the organ to bodyweight ratios calculated.

Many organs and tissues were processed for histopathological examination and checked for microscopically visible changes.

Body weights, hematological and clinical chemistry data, urine data (volume, pH value and specific weight), absolute and relative organ weights were analysed with the aid of a statistical program to show differences compared with the controls.

According to food consumption, mean substance intakes were as follows:

Males - low dose group               47 mg/kg bodyweight per day

intermediate dose group          227 mg/kg bodyweight per day

high dose group                      1172 mg/kg bodyweight per day

Females - low dose group      46 mg/kg bodyweight per day

intermediate dose group        236 mg/kg bodyweight per day

high dose group                          1193 mg/kg bodyweight per day

Behaviour and general health condition remained unaffected by the administration of the test compound in all groups. Body weight development, food and water consumption were comparable in all groups.

No signs of neurological disturbances, opacity of the refracting media of the eyes, damage to the oral mucosa or impairment of dental growth were observed in the control or treatment groups.

Hematological and clinical chemistry examinations revealed no abnormalities. No treatment-related changes were observed by urine analysis.

Organ weights were not affected by the administration of the test compound.

No compound-related effect was observed at necropsy.

The histopathological examinations revealed test compound in the lumen of the alimentary tract, adherent to the surface of the mucous membrane and/or the

food. The mucous membranes itself were uninjured.

In conclusion, Pigment Red 170 caused no detectable adverse effects in male and female Wistar rats when administered via food at the concentration of 12500 mg/kg food for 28 days.

With regard to the present study the 'No Observed Effect Level' is 12500 mg test item / kg food. This is equivalent to a mean daily compound intake of

1172 mg/kg bodyweight in males and 1193 mg/kg bodyweight in females.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
1 172 mg/kg bw/day
Study duration:
subacute
Species:
rat
Quality of whole database:
reliable with acceptable restrictions

Repeated dose toxicity: inhalation - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: inhalation - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - systemic effects

Endpoint conclusion
Endpoint conclusion:
no study available

Repeated dose toxicity: dermal - local effects

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

No classification

A subacute study performed using the analogue Pigment Red 170 gave a NOAEL of > 1000 mg/kg bw / day in the rat.